头皮冷却预防早期乳腺癌女性化疗所致脱发
Scalp cooling for the prevention of chemotherapy-induced alopecia in women with early breast cancer.
作者信息
Kojima Yasuyuki, Taruno Kanae, Harada Ken, Inoki Kazuya, Yamaji Noyuri, Noma Hisashi, Ota Erika, Hasegawa Takeshi
机构信息
Division of Breast Surgical Oncology, Department of Surgery, Showa Medical University, Tokyo, Japan.
Institute for Clinical Genetics and Genomics, Showa Medical University, Tokyo, Japan.
出版信息
Cochrane Database Syst Rev. 2025 Aug 1;8(8):CD016196. doi: 10.1002/14651858.CD016196.
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of scalp cooling for the prevention of hair loss from adjuvant or neoadjuvant chemotherapy in women with early breast cancer.
摘要
这是一项Cochrane系统评价（干预措施）的方案。目标如下：评估头皮冷却对预防早期乳腺癌女性辅助化疗或新辅助化疗所致脱发的利弊。
相似文献
1
Scalp cooling for the prevention of chemotherapy-induced alopecia in women with early breast cancer.
Cochrane Database Syst Rev. 2025 Aug 1;8(8):CD016196. doi: 10.1002/14651858.CD016196.
2
Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis.
Int J Cancer. 2015 Mar 1;136(5):E442-54. doi: 10.1002/ijc.29115. Epub 2014 Aug 11.
3
Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis.
Breast Cancer Res Treat. 2017 Jun;163(2):199-205. doi: 10.1007/s10549-017-4185-9. Epub 2017 Mar 8.
4
Scalp hypothermia to reduce chemotherapy-induced alopecia: A systematic review and meta-analysis.
Gynecol Oncol. 2024 Sep;188:71-80. doi: 10.1016/j.ygyno.2024.06.012. Epub 2024 Jun 26.
5
Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience.
Rev Recent Clin Trials. 2019;14(1):66-71. doi: 10.2174/1574887113666181120111104.
6
Photobiomodulation therapy in the prevention of chemotherapy-induced alopecia in breast cancer patients: a randomized controlled trial.
Lasers Med Sci. 2025 Jul 24;40(1):325. doi: 10.1007/s10103-025-04577-7.
7
[Scalp cooling for the prevention of chemotherapy-induced alopecia: systematic review and meta-analysis.].
Rev Esp Salud Publica. 2023 Mar 29;97:e202303024.
8
The scalp cooling therapy for hair loss in breast cancer patients undergoing chemotherapy: a systematic review and meta-analysis.
Support Care Cancer. 2021 Nov;29(11):6943-6956. doi: 10.1007/s00520-021-06188-8. Epub 2021 Apr 13.
9
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
JAMA. 2017 Feb 14;317(6):606-614. doi: 10.1001/jama.2016.21038.
10
COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
Breast Cancer Res Treat. 2019 Jan;173(1):135-143. doi: 10.1007/s10549-018-4983-8. Epub 2018 Sep 25.
本文引用的文献
1
Effectiveness of Scalp Cooling to Prevent Chemotherapy-Induced Alopecia in Patients Undergoing Breast Cancer Treatment: A Systematic Review and Meta-analysis.
Cancer Nurs. 2024;47(4):319-326. doi: 10.1097/NCC.0000000000001234. Epub 2023 Apr 4.
2
Chemotherapy, Alopecia, and Scalp Cooling Systems.
Actas Dermosifiliogr. 2022 Mar;113(3):278-283. doi: 10.1016/j.ad.2021.09.003. Epub 2021 Oct 12.
3
Efficacy of scalp cooling for prevention of chemotherapy induced alopecia: a systematic review and meta-analysis.
Eur Rev Med Pharmacol Sci. 2021 Aug;25(16):5090-5103. doi: 10.26355/eurrev_202108_26520.
4
Post-chemotherapy alopecia: what the dermatologist needs to know.
Int J Dermatol. 2021 Nov;60(11):1313-1317. doi: 10.1111/ijd.15812. Epub 2021 Aug 4.
5
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
6
Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres.
Eur J Cancer Care (Engl). 2021 May;30(3):e13395. doi: 10.1111/ecc.13395. Epub 2020 Dec 22.
7
Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines.
Ann Oncol. 2021 Feb;32(2):157-170. doi: 10.1016/j.annonc.2020.11.005. Epub 2020 Nov 25.
8
Prevention and Treatment of Chemotherapy-Induced Alopecia.
Dermatol Pract Concept. 2020 Jun 29;10(3):e2020074. doi: 10.5826/dpc.1003a74. eCollection 2020 Jul.
9
Improving Information Provision on Chemotherapy-Induced Alopecia and Scalp Cooling: A Comprehensive Approach Including A Website and Web-Based Decision Tool.
Asia Pac J Oncol Nurs. 2019 Oct-Dec;6(4):336-342. doi: 10.4103/apjon.apjon_19_19.
10
RoB 2: a revised tool for assessing risk of bias in randomised trials.
BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.
Zotero 插件